The wave of investments and acquisitions of Israeli tech companies by German corporations continues with great momentum.
Corindus Vascular Robotics, the Israeli-founded developer of precision vascular robotics has entered into a definitive agreement to be acquired by German medtech company Siemens Healthineers, the medical robotics company announced last week. Under the agreement, Siemens Medical Solutions, a subsidiary of Siemens Healthineers, will acquire all issued and outstanding shares of common stock of Corindus for $4.28 per share in cash. more on the deal from no camels
Israeli firms earn $14.48b in 66 exit deals in H1 of 2019 Figure represents the highest H1 exit value in the last five years in Israel, according to IVC–Meitar Exit Report.
In the first half of 2019, exit activity reached $14.48 billion in 66 deals, including one mega-deal—Mellanox Technologies, which was acquired by Nvidia for $6.9 billion (subject
to closing). Excluding the Mellanox deal, total exit value reached $7.58 billion in H1/2019.
Despite a slight decrease in the number of exits (which include: IPOs, M&As and buyouts), from 73 exits in H1/2018 to 66 exits in H1/2019, the total exit value in H1/2019 increased significantly from $6.49 billion in H1/2018 to $14.48 billion in H1/2019.
The average exit value in H1/2019 set a five-year record, reaching $116.6 million, almost double compared
with $63 million in 2015 annually.
